Artificial Intelligence May be Able to Detect Cancer Years in Advance

May 9, 2023

The artificial intelligence (AI) story is booming.

According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030.

And, according to Marketing AI Institute, “Artificial intelligence will, on average, boost rates of profitability by 38% and provide an economic boost of $14 trillion in additional gross value by 2035, according to research by Accenture.

Now, we’re learning it may be able to detect pancreatic cancer years in advance.

According to the article, a research team trained an AI algorithm on two data sets of nine million patient records in Denmark and in the U.S.

It was found that, “The model used disease codes and the timing of their occurrence to predict which patients were likely to develop pancreatic cancer in the future. Notably, many of the symptoms and disease codes were not directly related to or stemming from the pancreas. The AI model was tested on different versions for its ability to detect people at elevated risk of disease development within different timescales, ranging from six months to three years.”

“The researchers found that each version of the AI algorithm was substantially more accurate at predicting who would develop pancreatic cancer than current population-wide estimates of disease incidence. One significant advantage of the AI tool is that it can be used on all patients with available health records and medical history, not just those with a known family history or genetic predisposition for the disease.”

If AI can help detect pancreatic cancer, perhaps it can help detect others as well far sooner than traditional methods. And if that’s the case, perhaps more people can seek treatment options sooner than hoped, as well.

Investors seeking exposure to the AI boom may want to look at ETFs for diversification.

Global X Robotics & Artificial Intelligence ETF (BOTZ)

With an expense ratio of 0.68%, the Global X Robotics & Artificial Intelligence ETF invests in companies that will benefit from increased adoption and utilization of robotics and artificial intelligence, including those involved with industrial robotics and automation, non-industrial robots, and autonomous vehicles, according to Global X.

iShares Robotics and Artificial Intelligence ETF (IRBO)

With an expense ratio of 0.47%, the ETF provides exposure to companies at the forefront of robotics and artificial intelligence innovation.

ROBO Global Artificial Intelligence ETF (THNQ)

With an expense ratio of 0.75%, the ROBO Global Artificial Intelligence ETF invests in companies leading the AI revolution. THNQ includes companies developing the technology and infrastructure enabling AI, such as computing, data, and cloud services, as well as companies that apply AI in various verticals, from business processes to e-commerce and healthcare.

[featured sponsor]


[sponsored headlines]